Vicilin C72 Antibody

What is Vicilin C72 and what organisms express this protein?

Vicilin C72 is a seed storage protein belonging to the cupin superfamily that is primarily expressed in Gossypium hirsutum (Upland cotton) and Gossypium mexicanum . It is also known as Alpha-globulin B and functions as one of the major storage proteins in cottonseed . Vicilin proteins are typically found in the seeds of various plant species and serve as a nutrient reservoir during germination. In cotton specifically, the C72 gene encodes this ~50 kDa protein that shares structural similarities with other vicilin-family proteins found across different plant species .

What are the key specifications of commercially available Vicilin C72 Antibodies?

Commercially available Vicilin C72 Antibodies are typically polyclonal antibodies raised in rabbits through antigen-affinity purification methods . These antibodies have an IgG isotype and are specifically designed to recognize Vicilin C72 in Gossypium hirsutum (Upland cotton) and Gossypium mexicanum . They are validated for applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB), making them suitable for protein detection and identification in experimental settings . When selecting an antibody for your research, it's important to verify the specificity, cross-reactivity profile, and validated applications to ensure optimal performance in your experimental system.

How is Vicilin C72 structurally and functionally related to other seed storage proteins?

Vicilin C72 belongs to the vicilin family of seed storage proteins, which are part of the larger cupin superfamily characterized by a conserved β-barrel structural motif . Structurally, Vicilin C72 shares significant homology with other plant vicilins such as Ara h 1 from peanuts, as evidenced by cross-reactivity in immunological assays . This structural similarity extends to functional aspects, particularly concerning allergenicity. Both mass spectrometry and in silico analyses have confirmed peptide sequence similarities between cotton vicilin proteins and known allergens from peanuts and tree nuts . These vicilins typically function as nutrient reservoirs during seed germination, but their structural conservation across species also contributes to their allergenic potential due to shared epitopes that can be recognized by IgE antibodies .

What are the optimal extraction methods for isolating Vicilin C72 from cottonseed samples?

Research indicates that alkaline extraction methods are superior for isolating Vicilin C72 from cottonseed samples. Sequential extraction using both water-soluble and alkali-soluble fractions provides the most comprehensive protein profile, though the Vicilin C72 protein is predominantly found in the alkali-soluble fraction . The recommended protocol involves:

• Defatting cottonseed meal using hexane extraction

• Performing an initial water extraction to remove water-soluble proteins

• Following with alkaline extraction (typically pH 9-10) of the residual material

• Precipitating proteins using isoelectric precipitation methods

• Purifying further using chromatographic techniques such as ion-exchange or gel filtration

Studies demonstrate that while water extraction alone yields primarily lower molecular mass proteins, the alkaline extraction specifically enriches for proteins in the 10-150 kDa range, including the Vicilin C72 protein which migrates at approximately 49-51 kDa on SDS-PAGE gels .

What are the most effective immunoassay conditions for detecting Vicilin C72 using specific antibodies?

For optimal detection of Vicilin C72 using specific antibodies, researchers should consider the following immunoassay conditions:

For Western Blotting:

• Protein separation on 10-12% SDS-PAGE gels

• Transfer to nitrocellulose or PVDF membranes at 100V for 1 hour

• Blocking with 5% non-fat milk in TBST (Tris-buffered saline with 0.1% Tween-20)

• Primary antibody dilution: 1:1000-1:5000 in blocking buffer

• Incubation: Overnight at 4°C

• Detection using compatible secondary antibodies (anti-rabbit IgG)

For ELISA:

• Coating concentration: 1-5 μg/ml of antigen in carbonate buffer (pH 9.6)

• Blocking with 1-3% BSA in PBS

• Primary antibody dilution: 1:2000-1:10000

• Detection systems: HRP or AP-conjugated secondary antibodies

When optimizing these assays, it's important to note that Vicilin C72 appears as a doublet at approximately 49 and 51 kDa on Western blots . Additionally, using reducing agents such as dithiothreitol (DTT) may alter the detection pattern slightly, enhancing visibility of lower molecular weight fragments while maintaining signal intensity for the primary bands .

How can researchers assess cross-reactivity between Vicilin C72 and allergenic proteins from other plant sources?

To assess cross-reactivity between Vicilin C72 and allergenic proteins from other plant sources, researchers should implement a multi-faceted approach:

• Immunological Methods:

  • ELISA inhibition assays using allergic human sera to determine cross-reactivity percentages

  • Immunoblot analysis with pooled sera from allergic individuals

  • Basophil activation tests to assess functional cross-reactivity

• Mass Spectrometry Analysis:

  • Excise SDS-PAGE bands corresponding to IgE-reactive proteins

  • Perform tryptic digestion of proteins

  • Conduct liquid chromatography-coupled mass spectrometry (LC-MS/MS)

  • Identify matching peptides to known allergens

• Bioinformatic Analysis:

  • Conduct in silico epitope mapping to identify shared IgE-binding epitopes

  • Perform sequence alignment with known allergens such as Ara h 1 (peanut) and Ana o 2 (cashew)

  • Use allergen databases to predict potential cross-reactivity

Research has demonstrated that Vicilin C72 shows significant cross-reactivity with peanut allergens, particularly Ara h 1. In controlled studies, approximately 50% of peanut or tree-nut-allergic sera recognized purified native C72 and GC72A proteins in ELISA assays, with a smaller subset also recognizing recombinant forms of these proteins .

How can researchers differentiate between Vicilin C72 and GC72A in experimental samples?

Differentiating between Vicilin C72 and GC72A in experimental samples requires a combination of techniques due to their structural similarities and co-migration on standard gel systems. The following methodology is recommended:

• High-Resolution Protein Separation:

  • 2D gel electrophoresis combining isoelectric focusing (IEF) with SDS-PAGE

  • Capillary electrophoresis

  • High-performance liquid chromatography (HPLC)

• Immunological Distinction:

  • Development of epitope-specific monoclonal antibodies targeting unique regions

  • Competitive ELISA using recombinant versions of each protein

  • Immunoprecipitation followed by mass spectrometry analysis

• Molecular Genetic Approaches:

  • RT-PCR using gene-specific primers for C72 and GC72A

  • Expression of recombinant tagged versions of each protein

  • CRISPR-Cas9 gene editing to create knockout or tagged variants

Mass spectrometry analysis has identified unique peptide sequences that can serve as diagnostic markers for each protein. Studies have identified 21 unique peptides in the 51 kDa band and 20 unique peptides in the 49 kDa band that match Gossypium hirsutum vicilin C72, while different peptide patterns exist for GC72A . Researchers can exploit these differences through targeted proteomic approaches such as selected reaction monitoring (SRM) mass spectrometry to quantitatively distinguish between these closely related proteins.

What methodologies are available for investigating the allergenic epitopes of Vicilin C72?

Investigating the allergenic epitopes of Vicilin C72 requires a comprehensive approach combining experimental and computational methods:

• Epitope Mapping Techniques:

  • Peptide microarray analysis using overlapping synthetic peptides

  • Hydrogen/deuterium exchange mass spectrometry

  • X-ray crystallography of antibody-antigen complexes

  • Phage display libraries

• Bioinformatic Prediction Methods:

  • Computational epitope prediction algorithms

  • Structural modeling and molecular dynamics simulations

  • Comparative analysis with known allergen epitopes

  • Machine learning approaches using allergen databases

• Validation Methods:

  • Site-directed mutagenesis of predicted epitopes

  • Production of recombinant protein fragments

  • Competitive inhibition assays with synthetic peptides

  • Basophil activation tests with modified proteins

Research has demonstrated that Vicilin C72 contains epitopes that cross-react with anti-Ara h 1 antibodies, as shown by immunoblot assays . Furthermore, ELISA studies with purified native C72 protein showed recognition by IgE from approximately 50% of peanut or tree-nut-allergic sera . These findings suggest shared or structurally similar epitopes between Vicilin C72 and known allergens, making epitope mapping crucial for understanding the molecular basis of this cross-reactivity.

How can recombinant Vicilin C72 be produced for structural and functional studies?

Production of recombinant Vicilin C72 for structural and functional studies involves several key steps:

• Gene Cloning and Expression System Selection:

  • PCR amplification of the C72 gene from cotton genomic DNA or cDNA

  • Cloning into appropriate expression vectors with purification tags

  • Selection between prokaryotic (E. coli) or eukaryotic expression systems (yeast, insect cells)

• Optimization of Expression Conditions:

  • Induction parameters (temperature, inducer concentration, timing)

  • Codon optimization for the chosen expression system

  • Co-expression with chaperones if needed for proper folding

• Purification Strategies:

  • Affinity chromatography using His-tag, GST-tag, or other fusion tags

  • Ion exchange chromatography for further purification

  • Size exclusion chromatography for final polishing and buffer exchange

• Functional Validation:

  • Circular dichroism to confirm secondary structure

  • Thermal stability assays

  • Immunoreactivity comparison with native protein

Studies have successfully produced recombinant C72 and GC72A in E. coli systems, although recognition by allergic sera was lower compared to native proteins, suggesting potential differences in post-translational modifications or protein folding . When designing recombinant constructs, researchers should consider the impact of fusion tags on protein structure and function, and validate the recombinant protein against native standards using both structural and immunological assays.

What evidence supports the potential allergenicity of Vicilin C72 in food applications?

Multiple lines of evidence support the potential allergenicity of Vicilin C72 in food applications:

• Cross-Reactivity with Known Allergens:

  • Immunoblot assays demonstrate that C72 and GC72A are recognized by three different anti-Ara h 1 antibodies, indicating structural similarity to this major peanut allergen

  • In silico analysis confirms similarity of cotton vicilin proteins to peanut vicilin (Ara h 1) and cashew nut legumin (Ana o 2) IgE-binding epitopes

• Recognition by Allergic Sera:

  • ELISA studies with purified native C72 and GC72A show they are recognized by IgE from approximately 50% of peanut or tree-nut-allergic sera tested

  • A subset of these sera also recognized recombinant forms of C72 and GC72A, further confirming allergenicity

  • 25% of 32 samples from peanut and/or tree nut allergic individuals showed significant binding to glandless cottonseed protein extracts

• Molecular Features Associated with Allergenicity:

  • C72 belongs to the cupin superfamily, which includes numerous known food allergens

  • The protein shows resistance to certain degradation processes, a characteristic associated with allergenicity

  • Presence of similar IgE-binding epitopes as confirmed through mass spectrometry and epitope analysis

This evidence collectively suggests that Vicilin C72 represents a potential allergenic concern, particularly in novel food products derived from glandless cottonseed. Immunoblot analysis specifically identified two primary bands (at approximately 49 and 51 kDa) that were recognized by pooled allergic sera, with mass spectrometry confirming these contained Vicilin C72 .

How can researchers design experiments to assess the cross-reactivity potential of Vicilin C72 with peanut allergens?

To assess cross-reactivity potential between Vicilin C72 and peanut allergens, researchers should design experiments following this methodological framework:

• Subject Selection and Serum Collection:

  • Recruit well-characterized peanut-allergic subjects with confirmed clinical history

  • Include appropriate controls (non-allergic subjects and subjects allergic to unrelated allergens)

  • Collect and characterize sera for total and specific IgE levels

• Direct Binding Assays:

  • ELISA with purified Vicilin C72 and peanut allergens (particularly Ara h 1)

  • ImmunoCAP or equivalent quantitative assays to determine specific IgE levels

  • Immunoblotting with both native and denatured proteins to assess conformational vs. sequential epitopes

• Inhibition Studies:

  • ELISA inhibition assays using Vicilin C72 as inhibitor for binding to peanut allergens and vice versa

  • Dose-response inhibition curves to calculate IC50 values

  • Competitive immunoblotting to identify specific cross-reactive bands

• Functional Cross-Reactivity:

  • Basophil activation tests with both allergens

  • Mediator release assays using sensitized effector cells

  • Ex vivo stimulation of PBMCs from allergic donors

• Epitope Analysis:

  • Epitope mapping using overlapping peptides

  • Identification of shared epitopes through mass spectrometry and computational methods

  • Validation of epitopes through site-directed mutagenesis

Research data supports this approach, with previous studies demonstrating that while 13 of 25 peanut- and tree-nut-allergic samples bound cotton vicilins, the binding was generally weaker compared to peanut Ara h 1 binding . In one case (volunteer sample #5), glandless cottonseed vicilin binding was equivalent to Ara h 1 signal, although the pattern suggests that C72 and GC72A would be poor competitors for IgE binding to Ara h 1 .

What methodologies are available for investigating potential bioactive peptides derived from Vicilin C72?

Several methodological approaches are available for investigating bioactive peptides derived from Vicilin C72:

• In Silico Prediction Methods:

  • Computational analysis using databases such as BIOPEP-UWM to predict bioactive peptide sequences

  • Assessment of frequency of occurrence (A) and potential of release (AE) of bioactive fragments

  • Molecular docking studies to predict binding to target receptors

• Enzymatic Hydrolysis Approaches:

  • Simulated gastrointestinal digestion using sequential pepsin and pancreatin treatment

  • Specific enzymatic hydrolysis using proteases such as Alcalase or Aspergillus niger derived enzymes

  • Comparison of different enzyme combinations and conditions

• Peptide Identification and Characterization:

  • Fractionation of hydrolysates using techniques like RP-HPLC

  • Identification of bioactive peptides using tandem mass spectrometry

  • Synthesis of identified peptides for validation studies

• Bioactivity Assays:

  • Antioxidant activity assays (ABTS, DPPH, ORAC)

  • ACE inhibition assays for antihypertensive potential

  • Cell-based assays for anti-inflammatory or immunomodulatory effects

  • Assays for anti-diabetic properties such as α-amylase inhibition

In silico analysis indicates that cupin domain-containing proteins like Vicilin C72 are associated with a relatively high frequency of bioactive fragments, with ∑A values in the range of 1.4099–1.6102 . These values are slightly higher than previously published values for cupin domain-containing peanut and tree nut allergens (1.2749–1.3833), likely due to enrichment of databases with new peptides and activities . Release of bioactive peptides following gastrointestinal digestion appears somewhat limited, with ∑AE values for cupin proteins in the range of 0.0958–0.1753 .

How does Vicilin C72 compare structurally and functionally to vicilins from other plant species?

Vicilin C72 shares several structural and functional characteristics with vicilins from other plant species, while also displaying unique features:

• Structural Comparisons:

  • Like other vicilins, Vicilin C72 belongs to the cupin superfamily with characteristic β-barrel structural motifs

  • Mass spectrometry and sequence analysis reveal significant homology with vicilins from legumes, particularly peanut Ara h 1

  • Vicilin C72 appears as a ~50 kDa protein (specifically as a doublet at 49 and 51 kDa), similar to many plant vicilins

  • Unlike some legume vicilins that form trimeric structures, the quaternary structure of cotton vicilins remains less characterized

• Sequence Conservation:

  • Computational analyses demonstrate conservation of key cupin domain sequences

  • Shared epitopes with peanut and tree nut allergens suggest evolutionary conservation of certain protein regions

  • Specific differences in post-translational modifications may exist between cotton and legume vicilins

• Functional Similarities and Differences:

  • Primary function as seed storage protein is conserved across species

  • Allergenicity appears to be a shared feature, though with varying potency

  • Potential for generation of bioactive peptides is observed across vicilins from different species

  • Digestibility patterns may differ based on protein structure and post-translational modifications

What techniques can researchers use to study the evolutionary relationships between Vicilin C72 and related proteins?

Researchers can employ several techniques to study the evolutionary relationships between Vicilin C72 and related proteins:

• Phylogenetic Analysis Methods:

  • Multiple sequence alignment of vicilin sequences from diverse plant species

  • Construction of phylogenetic trees using maximum likelihood, Bayesian, or distance-based methods

  • Gene synteny analysis to examine conservation of genomic context

  • Molecular clock analyses to estimate divergence times

• Comparative Genomics Approaches:

  • Whole genome comparison across cotton species and other plants with known vicilin genes

  • Analysis of gene duplication events and paralogous relationships

  • Identification of conserved regulatory elements

  • Assessment of selection pressures using dN/dS ratios

• Structural Biology Techniques:

  • 3D structure prediction and comparison

  • Analysis of conserved domains and critical residues

  • Structural superimposition to identify conserved folding patterns

  • Mapping of conserved epitopes on 3D structures

• Functional Evolutionary Studies:

  • Comparative immunological studies across species

  • Recombinant expression of ancestral protein reconstructions

  • Analysis of species-specific post-translational modifications

  • Examination of bioactive peptide generation across evolutionary lineages

These approaches can reveal important insights about the origin and evolution of vicilin proteins in plants. Current research shows that cotton vicilins share significant sequence and structural similarities with peanut and tree nut allergens, suggesting common evolutionary origins . The cross-reactivity observed between cotton vicilins and peanut allergens provides functional evidence of this evolutionary relationship .

What are common challenges in detecting Vicilin C72 using immunological methods and how can they be addressed?

Researchers may encounter several challenges when detecting Vicilin C72 using immunological methods. Here are common issues and their solutions:

• Insufficient Extraction Efficiency:

  • Challenge: Incomplete extraction of Vicilin C72 from complex plant matrices

  • Solution: Optimize extraction by using sequential methods combining water extraction followed by alkaline extraction, as water extraction alone yields primarily lower molecular mass proteins while alkaline extraction enriches for proteins in the 10-150 kDa range, including Vicilin C72

• Cross-Reactivity and Specificity Issues:

  • Challenge: Non-specific binding or cross-reactivity with similar proteins

  • Solution: Use affinity-purified antibodies, perform pre-absorption with potential cross-reactive proteins, and validate with recombinant protein controls

• Protein Degradation:

  • Challenge: Degradation of target protein during sample preparation

  • Solution: Include protease inhibitors in extraction buffers, maintain samples at cold temperatures, and process samples quickly

• Variable Band Patterns in Western Blots:

  • Challenge: Appearance of multiple bands or inconsistent migration patterns

  • Solution: Note that Vicilin C72 appears as a doublet at approximately 49 and 51 kDa; use reducing agents like DTT to enhance visibility of certain fragments while optimizing gel percentage (10-12% SDS-PAGE gels work well)

• Low Signal-to-Noise Ratio:

  • Challenge: High background or weak signal in immunoassays

  • Solution: Optimize blocking conditions (5% non-fat milk in TBST is effective), antibody dilutions (1:1000-1:5000 for primary antibody), and incubation parameters (overnight at 4°C for primary antibody)

• Conformational Epitope Loss:

  • Challenge: Loss of antibody recognition due to protein denaturation

  • Solution: Consider native PAGE or dot blot methods if antibodies target conformational epitopes; compare results under reducing and non-reducing conditions

Research has shown that while water-soluble extracts (Glw) of cottonseed contain mostly lower molecular mass proteins that are not recognized by peanut and tree nut allergic IgE, both sequential (Gla) and alkaline-only (Gli) extracts contain Vicilin C72 that can be detected by appropriate antibodies .

How can researchers optimize recombinant expression systems for producing functional Vicilin C72?

Optimizing recombinant expression of functional Vicilin C72 requires addressing several key parameters:

• Expression System Selection:

  • Prokaryotic Systems (E. coli):

    • Advantages: High yield, simplicity, lower cost

    • Limitations: Lack of post-translational modifications, potential for inclusion bodies

    • Optimization: Use solubility-enhancing tags, cold-shock expression, or specialized strains

  • Eukaryotic Systems (Yeast, Insect, Mammalian):

    • Advantages: Better folding, post-translational modifications

    • Limitations: Lower yield, higher cost, more complex

    • Recommendation: Consider for functional studies requiring authentic protein structure

• Construct Design Strategies:

  • Include purification tags (His, GST) while considering their impact on protein folding

  • Optimize codon usage for the host organism

  • Consider removing signal peptides or problematic sequence regions

  • Design constructs both with and without fusion partners to compare functionality

• Expression Condition Optimization:

  • Induction parameters: Temperature (lower temperatures often improve folding)

  • Inducer concentration: Start with standard concentrations but titrate for optimization

  • Growth media: Enriched media may improve yields

  • Co-expression with chaperones to improve folding

• Purification and Validation:

  • Multi-step purification combining affinity, ion exchange, and size exclusion chromatography

  • Functional validation comparing recombinant protein with native protein

  • Assessment of secondary structure using circular dichroism

  • Immunological comparison with native protein

Research has demonstrated that recombinant C72 and GC72A can be successfully produced in E. coli, though recognition by allergic sera was lower compared to native proteins . This suggests that post-translational modifications or proper folding may be critical for maintaining full immunological properties, which should be considered when selecting expression systems and design strategies.

What methods can be used to address the variability in cross-reactivity studies with Vicilin C72?

Addressing variability in cross-reactivity studies with Vicilin C72 requires a multi-faceted approach:

• Standardization of Protein Preparations:

  • Implement consistent extraction and purification protocols

  • Characterize protein preparations using multiple methods (SDS-PAGE, mass spectrometry)

  • Quantify protein concentration using multiple methods (BCA, Bradford, amino acid analysis)

  • Develop reference standards with defined properties

• Serum Pool Standardization:

  • Create well-characterized serum pools with defined IgE levels

  • Include both high and low responders to capture spectrum of reactivity

  • Use ImmunoCAP or equivalent quantitative assays to standardize specific IgE levels

  • Include appropriate controls (non-allergic sera, sera from individuals allergic to unrelated allergens)

• Assay Protocol Optimization:

  • Establish standard operating procedures with detailed methods

  • Implement internal controls for day-to-day variation

  • Use reference curves for quantification

  • Perform replicate measurements and calculate coefficients of variation

• Statistical Approaches:

  • Implement robust statistical methods appropriate for immunological data

  • Use methods that account for non-normal distributions

  • Calculate confidence intervals for cross-reactivity measurements

  • Consider hierarchical or mixed-effects models for complex datasets

• Reporting Standards:

  • Document all relevant experimental parameters

  • Report measures of variability alongside means

  • Clearly define positive thresholds (e.g., "greater than two standard deviations above control samples")

  • Use standardized metrics for cross-reactivity

Research has shown significant variability in cross-reactivity between individual allergic sera and cotton vicilins. For example, while 13 of 25 peanut- and tree-nut-allergic samples recognized native cotton vicilins, only a subset (3 of 13 for C72 and 4 of 13 for GC72A) recognized recombinant forms . Similarly, among 32 peanut/tree nut allergic samples tested, only 8 produced IgE signals greater than two standard deviations above control samples . This variability underscores the importance of using sufficiently large and well-characterized sample sets and implementing standardized approaches.